BiotechTube

Live-attenuated CHIKV vaccine VLA1553

Pre-clinicalActive
0 watching 0 views this week💤 Quiet
18
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Chikungunya Virus Infection

Conditions

Chikungunya Virus Infection

Trial Timeline

Sep 22, 2025 → Dec 31, 2026

NCT ID
NCT07163845

About Live-attenuated CHIKV vaccine VLA1553

Live-attenuated CHIKV vaccine VLA1553 is a pre-clinical stage product being developed by Valneva SE for Chikungunya Virus Infection. The current trial status is active. This product is registered under clinical trial identifier NCT07163845. Target conditions include Chikungunya Virus Infection.

Hype Score Breakdown

Clinical
5
Activity
2
Company
5
Novelty
2
Community
1

Clinical Trials (3)

NCT IDPhaseStatus
NCT07254702Pre-clinicalRecruiting
NCT07347002Pre-clinicalRecruiting
NCT07163845Pre-clinicalActive

Competing Products

20 competing products in Chikungunya Virus Infection

See all competitors
ProductCompanyStageHype Score
CHIKV VLP/unadjuvanted + CHIKV VLP/adjuvanted + PlaceboBavarian NordicPhase 2
49
ChikungunyaBavarian NordicPhase 2
49
CHIKV VLP vaccine booster + Placebo boosterBavarian NordicPhase 3
74
CHIKV VLP/adjuvant + PlaceboBavarian NordicPhase 3
74
CHIKV VLP, adjuvantedBavarian NordicPhase 2
49
CHIKV VLP/adjuvant + PlaceboBavarian NordicPhase 3
74
CHIKV VLP vaccine + PlaceboBavarian NordicPhase 3
74
CHIKV VLP vaccine + PlaceboBavarian NordicPhase 3
74
Live-attenuated CHIKV vaccine VLA1553Valneva SEPre-clinical
18
VLA1553Valneva SEPhase 3
72
Biological Vaccine VLA1553Valneva SEPhase 3
72
VLA1553 full dose + VLA1553 half dose + ControlValneva SEPhase 2
47
Active + PlaceboValneva SEPhase 3
72
Live-attenuated CHIKV vaccine VLA1553 + Vaccine(s) approved for use during pregnancy by the MoHValneva SEPre-clinical
18
VLA1553Valneva SEPhase 3
72
VLA1553 + ControlValneva SEPhase 3
72
VLA1553 + PlaceboValneva SEPhase 3
72
VLA1553Valneva SEPhase 1
28
Live-attenuated CHIKV vaccine VLA1553Valneva SEPre-clinical
18
INTERCEPT PlateletsCerusPre-clinical
15

Other Products from Valneva SE

IXIARO®- Japanese Encephalitis vaccineApproved
80
IXIARO®Approved
80
Japanese Encephalitis purified inactivated vaccinePhase 3
72
IC51 + HAVRIXPhase 3
72
IXIARO + IXIAROPhase 3
72